Product Code: ETC070068 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Philippines biobanking market is expected to witness substantial growth over the forecast period. This is attributed to the increasing focus of government and private institutions in developing a well-equipped infrastructure for storing biological samples for research purposes, growing prevalence of chronic diseases, technological advancements in storage systems, and rise in public-private partnerships. Furthermore, the rising awareness among people regarding personalized medicine will also support the growth of this market
Increasing number of CROs and pharmaceutical companies entering into collaborations with clinical trial sites: The presence of several CROs and pharmaceutical companies have led to an increase in collaborations between them leading to an increased demand for better quality bio specimen collection & management services from clinical trials sites like hospitals, diagnostic laboratories etc. Additionally, growing demand for biospecimen banking solutions: Biospecimens are increasingly being used by researchers as they provide insights into patients??? past medical history which helps them make informed decisions on treatments or cures. Consequently, there has been a vast increase in demand from hospitals & labs for advanced biospecimen banking solutions that enable efficient storage & retrieval operations while ensuring patient privacy. Further, there has been rapid adoption of automated technology such as computerized laboratory information systems (LIS) which helps healthcare professionals efficiently carry out sample processing without compromising accuracy or efficiency along with providing secure access control mechanisms enabling safe sharing & exchange of data across multiple stakeholders including doctors, nurses etc. In addition other technologies such as barcode scanners are also being widely adopted contributing further towards efficiency gains within biobanks.
According to World Health Organization (WHO), it was estimated that around 3M Filipinos were suffering from diabetes while another 5 million were afflicted by hypertension during 2019-2021 period resulting in an overall rise in need for effective diagnosis methods using biological samples leading to increased investment into biobanking activities within Philippines healthcare sector both at government level as well private entities thereby driving its growth prospectus ahead. Additionally, government initiatives towards development infrastructure related projects : The Philippine government has taken numerous steps towards strengthening its biomedical research capabilities through various programs such as ???Adopt A Biomedical Laboratory Program??? aimed at establishing more than 100 new facilities across various regions throughout country thus creating ample scope for boosting biobanking industry within region.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Biobanking Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Biobanking Market Revenues & Volume, 2020 & 2027F |
3.3 Philippines Biobanking Market - Industry Life Cycle |
3.4 Philippines Biobanking Market - Porter's Five Forces |
3.5 Philippines Biobanking Market Revenues & Volume Share, By Type, 2020 & 2027F |
3.6 Philippines Biobanking Market Revenues & Volume Share, By Applications, 2020 & 2027F |
3.7 Philippines Biobanking Market Revenues & Volume Share, By Sample Type, 2020 & 2027F |
4 Philippines Biobanking Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Biobanking Market Trends |
6 Philippines Biobanking Market, By Types |
6.1 Philippines Biobanking Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Biobanking Market Revenues & Volume, By Type, 2018 - 2027F |
6.1.3 Philippines Biobanking Market Revenues & Volume, By Equipment, 2018 - 2027F |
6.1.4 Philippines Biobanking Market Revenues & Volume, By Consumables, 2018 - 2027F |
6.1.5 Philippines Biobanking Market Revenues & Volume, By Services, 2018 - 2027F |
6.1.6 Philippines Biobanking Market Revenues & Volume, By Software, 2018 - 2027F |
6.2 Philippines Biobanking Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Philippines Biobanking Market Revenues & Volume, By Regenerative Medicine, 2018 - 2027F |
6.2.3 Philippines Biobanking Market Revenues & Volume, By Life Science Research, 2018 - 2027F |
6.2.4 Philippines Biobanking Market Revenues & Volume, By Clinical Research, 2018 - 2027F |
6.3 Philippines Biobanking Market, By Sample Type |
6.3.1 Overview and Analysis |
6.3.2 Philippines Biobanking Market Revenues & Volume, By Blood Products, 2018 - 2027F |
6.3.3 Philippines Biobanking Market Revenues & Volume, By Human Tissues, 2018 - 2027F |
6.3.4 Philippines Biobanking Market Revenues & Volume, By Nucleic Acids, 2018 - 2027F |
6.3.5 Philippines Biobanking Market Revenues & Volume, By Cell Lines, 2018 - 2027F |
6.3.6 Philippines Biobanking Market Revenues & Volume, By Biological Fluids, 2018 - 2027F |
6.3.7 Philippines Biobanking Market Revenues & Volume, By Human Waste Products, 2018 - 2027F |
7 Philippines Biobanking Market Import-Export Trade Statistics |
7.1 Philippines Biobanking Market Export to Major Countries |
7.2 Philippines Biobanking Market Imports from Major Countries |
8 Philippines Biobanking Market Key Performance Indicators |
9 Philippines Biobanking Market - Opportunity Assessment |
9.1 Philippines Biobanking Market Opportunity Assessment, By Type, 2020 & 2027F |
9.2 Philippines Biobanking Market Opportunity Assessment, By Applications, 2020 & 2027F |
9.3 Philippines Biobanking Market Opportunity Assessment, By Sample Type, 2020 & 2027F |
10 Philippines Biobanking Market - Competitive Landscape |
10.1 Philippines Biobanking Market Revenue Share, By Companies, 2020 |
10.2 Philippines Biobanking Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |